🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, phase 1, "3+3" dose escalating study of tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02380287
Treatments Being Tested
BCD-085-5 is an International, Multicenter, Randomized, Double-blind, Place...
Status
Completed
Location
Non-governmental Healthcare Institution "Railway Clinical hospital on the Chelyabinsk Station of JSC Russian Railways"
Start Date
2018-02-09
Trial ID
NCT03447704
BCD-085-3 is a next step in clinical investigation of BCD-085. BCD-085 is a...
Status
Completed
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02763111
BCD-085 is an innovative drug, a monoclonal antibody against interleukin-17...
Status
Completed
Location
BIOCAD
Start Date
2017-12-26
Trial ID
NCT03390101
Treatments Being Tested
Study BCD-085-8/PATERA is a multicentre double-blind placebo-controlled Pha...
Status
Completed
Location
1st City Clinical Hospital
Start Date
2018-07-25
Trial ID
NCT03598751
BCD-085 is an innovative drug, anti-interleukin-17 monoclonal antibody. The...
Status
Terminated
Location
State Budgetary Higher Vocational Education Institution I.M. Sechenov First Moscow State Medical University
Start Date
2018-04-27
Trial ID
NCT03476993
Treatments Being Tested
BCD-085-2 is a next step in clinical investigation of BCD-085. BCD-085 is a...
Status
Completed
Location
BIOCAD
Start Date
2016-06
Trial ID
NCT02762994